{
    "organizations": [],
    "uuid": "420fedba564660da355133ad845e27b1f9b48266",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-xspray-pharma-proposes-directed-is/brief-xspray-pharma-proposes-directed-issue-of-1-35-mln-shares-idUSASM000IOJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Xspray Pharma proposes directed issue of 1.35 mln shares",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Xspray Pharma Ab (Publ):\n* XSPRAY PHARMA PROPOSES A DIRECTED ISSUE OF 1,350,000 SHARES CORRESPONDING TO APPROXIMATELY SEK 88 MILLION TO EXPAND THE PRODUCT PORTFOLIO\n* ‍HAS RESOLVED TO PROPOSE A DIRECTED SHARE ISSUE OF 1.35 MILLION SHARES AT A SUBSCRIPTION PRICE OF SEK 65 PER SHARE​\n* ‍SHAREHOLDERS REPRESENTING ABOUT 67.2 PERCENT OF SHARES OF XSPRAY PHARMA HAVE UNDERTAKEN TO VOTE IN FAVOUR OF ISSUE​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-31T02:48:00.000+02:00",
    "crawled": "2018-01-31T16:43:20.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "xspray",
        "pharma",
        "ab",
        "publ",
        "xspray",
        "pharma",
        "proposes",
        "directed",
        "issue",
        "share",
        "corresponding",
        "approximately",
        "sek",
        "million",
        "expand",
        "product",
        "portfolio",
        "resolved",
        "propose",
        "directed",
        "share",
        "issue",
        "million",
        "share",
        "subscription",
        "price",
        "sek",
        "per",
        "representing",
        "percent",
        "share",
        "xspray",
        "pharma",
        "undertaken",
        "vote",
        "favour",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}